Market Overview:
The global diabetes management market is expected to grow at a CAGR of 10.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of diabetes, growing awareness about diabetes, and technological advancements in the field of diabetes management. The global diabetic monitoring devices market is expected to grow at a CAGR of 11.1% from 2018 to 2030. The growth in this segment can be attributed to the increasing prevalence of type 2 diabetes, growing awareness about early diagnosis and treatment options for type 2 diabetes, and technological advancements in diabetic monitoring devices. The global diagnostic devices market for diagnosing type 1 and type 2 diabetes is expected to grow at a CAGR of 9% from 2018-2030 owing primarily due rising incidence rates globally for both types 1 as well as type 2 Diabetes Mellitus (DM).
Product Definition:
Diabetes management is the process of taking steps to prevent and control diabetes. Diabetes management is important because it can help people with diabetes stay healthy and avoid serious health problems.
Monitoring Devices:
The global monitoring devices, it's usage and growth factor in diabetes management market is expected to grow at a CAGR of XX% during the forecast period. The factors that are driving this market include increasing prevalence of lifestyle diseases such as diabetes and cardiovascular disorders along with growing awareness about self-monitoring devices among patients. Moreover, continuous technological advancements in these products including advanced sensors and wireless technology are also contributing towards the growth of this market.
Diagnostic Devices:
Diagnostic devices and it's usage in diabetes management market is expected to grow at a lucrative rate during the forecast period. The major factor that propels the growth of this market includes increasing prevalence of diabetes, growing awareness about advanced diagnostic devices among patients, technological advancements in these products and frequent product launches by the manufacturers. For instance, In June 2016 Roche launched an Accu-Chek Guide blood glucose monitoring system which can be used by people with or without a smartphone app.
Application Insights:
The hospital segment dominated the market in 2017 and is expected to maintain its dominance over the forecast period. The hospital-based management of diabetes requires a higher number of devices as compared to home care or clinic-based management. Hospital based management involves more frequent visits by healthcare professionals for monitoring blood glucose levels, diet intake, and medication adjustment. These factors are anticipated to drive demand for diabetes devices & therapies in the hospital segment over the forecast period.
Clinic based diabetes management involves consultation with a doctor regarding diagnosis, treatment planning, and follow up care involving multiple patients with different types of diabetes mellitus (DM). This type of Diabetes Management Market is expected to witness growth at a CAGR exceeding 7% from 2018 to 2030 owing to increasing awareness about lifestyle modifications along with technological advancements that help manage blood glucose levels at minimal costs while providing accurate results.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of diabetes and growing awareness about its treatment. In addition, presence of major players such as Abbott, Novo Nordisk A/S, and Sanofi are also contributing towards growth in this region. For instance, Novo Nordisk has launched a new generation insulin patch that will help diabetic patients avoid injections completely while still being able to check blood sugar levels with out any extra devices or app changes.
Asia Pacific is estimated to be fastest-growing regional market from 2018 to 2030 due high prevalence of diabetes coupled with rising healthcare expenditure in countries like India & China & Japan). Moreover, increasing number of product launches by key companies such as BMS (Bayer), Tandem Diabetes Care; CGM Technology; and FreeStyle Navigator are also driving growth in this region.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is mainly due to the changing lifestyle and dietary habits of people across the world. As a result, there is a growing demand for effective diabetes management products and services.
- Rising awareness about diabetes: There has been a significant increase in the awareness about diabetes in recent years. This has led to an increased demand for better diagnosis and treatment options for the disease.
- Technological advancements: The field of diabetes management is constantly evolving with new technological advancements being made every day. This has led to the development of innovative products and therapies that are helping people manage their condition more effectively.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetes Management Market Research Report
By Type
Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices, Other Devices
By Application
Hospital, Clinic, Home Care
By Companies
Ascensia Diabetes Care, Abbott Laboratories, Medtronic, Roche, Dexcom, Insulet Corporation, Tandem Diabetes Care, LifeScan, AgaMatrix, Animas, ARKRAY, BD, Beta Bionics., Eli Lilly
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Diabetes Management Market Report Segments:
The global Diabetes Management market is segmented on the basis of:
Types
Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices, Other Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Home Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ascensia Diabetes Care
- Abbott Laboratories
- Medtronic
- Roche
- Dexcom
- Insulet Corporation
- Tandem Diabetes Care
- LifeScan
- AgaMatrix
- Animas
- ARKRAY
- BD
- Beta Bionics.
- Eli Lilly
Highlights of The Diabetes Management Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monitoring Devices
- Diagnostic Devices
- Insulin Delivery Devices
- Other Devices
- By Application:
- Hospital
- Clinic
- Home Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetes Management Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diabetes management is the process of managing diabetes through diet, exercise, and medication.
Some of the major players in the diabetes management market are Ascensia Diabetes Care, Abbott Laboratories, Medtronic, Roche, Dexcom, Insulet Corporation, Tandem Diabetes Care, LifeScan, AgaMatrix, Animas, ARKRAY, BD, Beta Bionics., Eli Lilly.
The diabetes management market is expected to grow at a compound annual growth rate of 10.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diabetes Management Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diabetes Management Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diabetes Management Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diabetes Management Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diabetes Management Market Size & Forecast, 2020-2028
4.5.1 Diabetes Management Market Size and Y-o-Y Growth
4.5.2 Diabetes Management Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Monitoring Devices
5.2.2 Diagnostic Devices
5.2.3 Insulin Delivery Devices
5.2.4 Other Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Home Care
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diabetes Management Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diabetes Management Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Monitoring Devices
9.6.2 Diagnostic Devices
9.6.3 Insulin Delivery Devices
9.6.4 Other Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Home Care
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Monitoring Devices
10.6.2 Diagnostic Devices
10.6.3 Insulin Delivery Devices
10.6.4 Other Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Home Care
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Monitoring Devices
11.6.2 Diagnostic Devices
11.6.3 Insulin Delivery Devices
11.6.4 Other Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Home Care
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Monitoring Devices
12.6.2 Diagnostic Devices
12.6.3 Insulin Delivery Devices
12.6.4 Other Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Home Care
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Monitoring Devices
13.6.2 Diagnostic Devices
13.6.3 Insulin Delivery Devices
13.6.4 Other Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Home Care
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diabetes Management Market: Competitive Dashboard
14.2 Global Diabetes Management Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ascensia Diabetes Care
14.3.2 Abbott Laboratories
14.3.3 Medtronic
14.3.4 Roche
14.3.5 Dexcom
14.3.6 Insulet Corporation
14.3.7 Tandem Diabetes Care
14.3.8 LifeScan
14.3.9 AgaMatrix
14.3.10 Animas
14.3.11 ARKRAY
14.3.12 BD
14.3.13 Beta Bionics.
14.3.14 Eli Lilly
